全文获取类型
收费全文 | 96801篇 |
免费 | 6594篇 |
国内免费 | 510篇 |
专业分类
耳鼻咽喉 | 1207篇 |
儿科学 | 2286篇 |
妇产科学 | 1386篇 |
基础医学 | 12429篇 |
口腔科学 | 2310篇 |
临床医学 | 9533篇 |
内科学 | 21323篇 |
皮肤病学 | 1517篇 |
神经病学 | 9227篇 |
特种医学 | 3950篇 |
外国民族医学 | 1篇 |
外科学 | 16056篇 |
综合类 | 801篇 |
一般理论 | 194篇 |
预防医学 | 6550篇 |
眼科学 | 1833篇 |
药学 | 5857篇 |
中国医学 | 139篇 |
肿瘤学 | 7306篇 |
出版年
2023年 | 864篇 |
2022年 | 1498篇 |
2021年 | 3285篇 |
2020年 | 1820篇 |
2019年 | 2822篇 |
2018年 | 3317篇 |
2017年 | 2350篇 |
2016年 | 2541篇 |
2015年 | 2854篇 |
2014年 | 3943篇 |
2013年 | 5045篇 |
2012年 | 7638篇 |
2011年 | 7739篇 |
2010年 | 4266篇 |
2009年 | 3702篇 |
2008年 | 6369篇 |
2007年 | 6140篇 |
2006年 | 5948篇 |
2005年 | 5864篇 |
2004年 | 5280篇 |
2003年 | 4844篇 |
2002年 | 4350篇 |
2001年 | 616篇 |
2000年 | 487篇 |
1999年 | 686篇 |
1998年 | 891篇 |
1997年 | 710篇 |
1996年 | 574篇 |
1995年 | 565篇 |
1994年 | 451篇 |
1993年 | 459篇 |
1992年 | 366篇 |
1991年 | 324篇 |
1990年 | 296篇 |
1989年 | 288篇 |
1988年 | 291篇 |
1987年 | 265篇 |
1986年 | 289篇 |
1985年 | 292篇 |
1984年 | 357篇 |
1983年 | 311篇 |
1982年 | 339篇 |
1981年 | 339篇 |
1980年 | 264篇 |
1979年 | 151篇 |
1978年 | 193篇 |
1977年 | 181篇 |
1976年 | 130篇 |
1975年 | 134篇 |
1974年 | 132篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Vogler SA Fenton SJ Scaife ER Book LS Jackson D Nichol PF Meyers RL 《Journal of pediatric surgery》2008,43(6):1006-1010
Background
In infants with gastroschisis antenatal closure of the umbilical defect results in a proximal atresia with ischemia and/or volvulus of the extracorporeal midgut. It has been described as “closed gastroschisis” or “vanishing midgut.”Methods
A 10-year review of 219 gastroschisis patients identified 10 infants with this rare complication.Results
In these 10 infants, the extracorporeal midgut was invariably matted and fibrosed. In 3 cases, the midgut had completely “vanished.” In the remaining 7 cases, the remnant midgut was surgically reduced into the abdominal cavity with care not to compromise the diminutive vascular pedicle. Abdominal exploration was performed several weeks later to reestablish bowel continuity; 4 required an ostomy and 2 underwent a serial transverse enteroplasty. Mean residual length of salvaged small bowel was 79 cm with retention of the distal half of the colon. Eight infants survived the initial hospitalization, with a mean length of stay of 121 days and mean hospital charge of $287,094. Six of the 7 long-term survivors have been completely weaned off total parenteral nutrition.Conclusion
A nihilistic attitude toward infants with closed gastroschisis may not be uniformly supported because in the majority of these infants' long-term independence from total parenteral nutrition was achieved. 相似文献992.
Sorenson BS Banton KL Frykman NL Leonard AS Saltzman DA 《Journal of pediatric surgery》2008,43(6):1153-1158
Purpose
The current management of osteosarcoma (OS) entails an aggressive preoperative and postoperative chemotherapeutic regimen with limb salvage surgery. Despite these efforts, relapse-free survival is less than 60% in patients with classic OS, whereas most patients relapse with pulmonary metastases. In these studies, we sought to prevent the establishment of pulmonary metastases from OS with a single oral dose of SalpIL2.Methods
Mice were administered attenuated Salmonella typhimurium with (SalpIL2) and without a gene for human interleukin 2 (Sal-NG) 7 days before challenge with 2 × 105 OS cells via tail vein. Three weeks after injection, mice were harvested for splenic lymphocytes and tumor enumeration.Results
Prophylaxis with attenuated SalpIL2 significantly reduces pulmonary metastases in number and volume (P < .0001 and P < .0001) with respect to saline controls. Furthermore, splenic natural killer cell populations were increased 396% with SalpIL2 (P < .0007) and 426% with Sal-NG (P < .0003) compared to nontreated groups.Conclusions
Host natural killer response is greatly amplified and maybe partially responsible for the effective immune response against the formation of pulmonary metastases. A single oral dose of SalpIL2 may be a novel form of adjuvant therapy for patients after early detection of primary OS. 相似文献993.
994.
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine‐enhanced hepatobiliary phase MRI 下载免费PDF全文
Marion Roux MD Frederic Pigneur MD Julien Calderaro MD Laurence Baranes MD Mélanie Chiaradia MD Lambros Tselikas MD Thomas Decaens MD PhD Charlotte Costentin MD Alexis Laurent MD PhD Daniel Azoulay MD PhD Ariane Mallat MD PhD Elie‐Serge Zafrani MD PhD Alain Rahmouni MD PhD Alain Luciani MD PhD 《Journal of magnetic resonance imaging : JMRI》2015,42(5):1249-1258
995.
996.
Hinged elbow external fixation for severe elbow contracture 总被引:2,自引:0,他引:2
Ring D Hotchkiss RN Guss D Jupiter JB 《The Journal of bone and joint surgery. American volume》2005,87(6):1293-1296
BACKGROUND: When it was first introduced, it was hoped that hinged external fixation with a built-in gear mechanism for applying passive motion and static progressive stretch by turning a dial would improve the arc of ulnohumeral motion, by gradually stretching contracted muscles, after open release of a severe elbow contracture. METHODS: Forty-two patients were evaluated at an average of thirty-nine months after operative release of a severe posttraumatic elbow contracture (defined as < or =40 degrees of motion). Twenty-three patients had been treated, during the early part of the study, with a hinged external fixator that incorporated a worm gear to apply static progressive stretch postoperatively. These patients were compared with nineteen patients who had been treated without hinged external fixation during the later part of the study, when the hinge was used less frequently. The operative techniques did not otherwise change during the study period. Demographic and injury characteristics as well as associated problems were comparable between the two groups. RESULTS: The average gain in the range of motion after the index procedure was 89 degrees in the patients treated with a hinge and 78 degrees in those treated without a hinge, an insignificant difference with the numbers available (p = 0.175). Complications associated with use of the hinge included five pin-track infections, one case of pin-track osteomyelitis, one ulnar fracture through a pin site, two broken Schanz screws, and two cases of irritation of the ulnar nerve. CONCLUSIONS: Open release of a severe elbow contracture results in a substantial gain in motion, with or without hinged elbow fixation. The slightly greater improvement in motion provided by the hinge does not justify the associated increase in risk, expense, and complications. 相似文献
997.
BACKGROUND: Interleukin (IL)-12-producing dendritic cells (IL-12+DC) polarize T helper (Th) differentiation toward Th1, whereas IL-10+DC induce Th differentiation toward Th2. We investigated DC and plasma cytokine patterns early and late after transplantation. METHODS: Twenty-five hospitalized renal-transplant recipients without acute rejection or infection early (<40 days) posttransplant, 32 symptom-free outpatients with long-term functioning transplants (2,762+/-2,423 days posttransplant), and 17 healthy controls were studied. The intracellular production of IL-12 and IL-10 in CD11c+ CD83+ CD40+ DC was measured in freshly obtained whole blood using four-color fluorescence flow cytometry. In addition, plasma cytokine levels were investigated. RESULTS: Early and late posttransplant patients had significantly lower proportions of IL-12+DC (early: P=0.001; late: P=0.034) and lower ratios of IL-12+/IL-10+DC (early: P=0.0001; late: P<0.0001) than healthy controls. IL-10+DC (P=0.0004) and IL-12+DC (P=0.002) increased with time posttransplant in association with dose reductions of cyclosporine (IL-10+DC: P=0.003; IL-12+DC: P=0.005), methylprednisolone (IL-10+DC: P<0.0001; IL-12+DC: P=0.001) and mycophenolate mofetil (IL-10+DC: P<0.0001; IL-12+DC: P=0.004). Both IL-10+DC and IL-12+DC were associated with low plasma IL-10 (IL-10+DC: P=0.010; IL-12+DC: P=0.011) and high plasma IL-6 (IL-10+DC: P=0.001; IL-12+DC: P=0.009). IL-10+DC were also associated with high plasma levels of IL-3 (P=0.003), interferon (IFN)-gamma (P=0.014), and IL-2 (P=0.058). CONCLUSION: IL-10+DC and IL-12+DC in peripheral blood are associated with time after transplantation and dosage of immunosuppression. IL-10+DC dominate late posttransplant in the presence of Th1 plasma cytokines (high IFN-gamma and IL-2), high IL-3, and low IL-10. These findings could be a reflection of immunoregulatory processes favoring long-term allograft acceptance. 相似文献
998.
Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). 总被引:1,自引:0,他引:1
Achim Koch Volker Daniel Thomas J Dengler Philipp Albert Schnabel Siegfried Hagl Falk-Udo Sack 《The Journal of heart and lung transplantation》2005,24(6):708-713
BACKGROUND: Cytolytic induction therapy with anti-thymocyte globulin (ATG) should induce effective immunosuppression, with a low rate of rejection in the initial phase after heart transplantation. Induction therapy with ATG allows post-operative renal recovery without the negative effects of highly nephrotoxic cyclosporine levels. An increased rate of infection is a common problem, however, and has been associated with "over-immunosuppression" early after transplantation. Therefore, we investigated whether reduced T-cell-adapted ATG induction therapy could be performed without increasing the risk of graft loss by rejection and whether reductions in infection rates and costs are possible. METHODS: Between March 1999 and December 2002, T-cell-adapted ATG induction therapy with ATG (Sangstat) (1.5 mg/kg) was given to 62 heart transplant recipients (study group) starting on post-operative Days 1 to 6. T-lymphocyte sub-populations were screened daily using flow cytometry. If total lymphocytes were <100/microl (reference 1,300 to 2,300/microl), T-helper lymphocytes (CD4+) <50/microl (reference >500/microl) and T-suppressor cells (CD8+) <50/microl (reference >300/microl), then no ATG was given. Further immunosuppression was continued with triple therapy consisting of methylprednisolone, azathioprine and cyclosporine. An historic group of heart transplant recipients given a full-dose ATG regimen for 8 days served as controls. These recipients were treated with ATG (Merieux 1.5 mg/kg) until reaching monoclonal cyclosporine levels of >300 mg/dl. Additional immunosuppressive treatment did not differ. Patients in both groups received systemic antibiotics (Imipenem) peri-operatively. Results of routine endomyocardial biopsies and rates of infections were examined. RESULTS: Study group patients were older (52 +/- 10 vs 49 +/- 14 years). In the study group, mean cumulative ATG dose was reduced significantly to 596 +/- 220 mg (p < 0.05) for 3.9 +/- 1.6 days compared with 1,159 +/- 376 mg for 6.9 +/- 1.1 days in the control group. The rate of cytomegalovirus (CMV) seroconversion was 23% in the study group compared with 13% in the control group. Rate of deep sternal infections was lower in the study group (1.6% vs 3.2%). The mean rejection rate in the first 3 months was 0.4 +/- 0.7 for the study patients (185 biopsies) vs 1.1 +/- 1.7 for controls (237 biopsies). All biopsies with ISHLT Grade >2 were treated successfully with 1,000 mg of methylprednisolone intravenously for 3 days. Both groups showed a similar 1-year survival rate (study 88%, control 89%). CONCLUSIONS: T-cell-adapted ATG induction therapy can be a helpful tool for individualized immunosuppression. It is not associated with an increased rate of rejection. Lower doses of immunosuppression help to minimize the rates of infection. In addition, cytolytic induction therapy combined with reduced ATG results in significant cost reduction. 相似文献
999.
1000.
Joseph Michaels th MD ; Michael Dobryansky MD ; Robert D.. Galiano MD ; Kirit A.. Bhatt MD ; Russell Ashinoff MD ; Daniel J. Ceradini MD ; Geoffrey C.. Gurtner MD 《Wound repair and regeneration》2005,13(5):506-512
The prevention of new blood vessel growth is an increasingly attractive strategy to limit tumor growth. However, it remains unclear whether anti-angiogenesis approaches will impair wound healing, a process thought to be angiogenesis dependent. Results of previous studies differ as to whether angiogenesis inhibitors delay wound healing. We evaluated whether endostatin at tumor-inhibiting doses delayed excisional wound closure. C57/BL6J mice were treated with endostatin or phosphate-buffered solution 3 days prior to the creation of two full-thickness wounds on the dorsum. Endostatin was administered daily until wound closure was complete. A third group received endostatin, but also had daily topical vascular endothelial growth factor applied locally to the wound. Wound area was measured daily and the wounds were analyzed for granulation tissue formation, epithelial gap, and wound vascularity. Endostatin-treated mice showed a significant delay in wound healing. Granulation tissue formation and wound vascularity were significantly decreased, but reepithelialization was not effected. Topical vascular endothelial growth factor application to wounds in endostatin-treated mice resulted in increased granulation tissue formation, increased wound vascularity, and wound closure approaching that of control mice. This study shows that the angiogenesis inhibitor endostatin delays wound healing and that topical vascular endothelial growth factor is effective in counteracting this effect. 相似文献